NCT05862207

Brief Summary

To study prevalence, risk factors, possible etiologies, clinical presentation and outcome of nephrocalcinosis in children at Sohag University Hospital.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2023

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 8, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 17, 2023

Completed
15 days until next milestone

Study Start

First participant enrolled

June 1, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

June 13, 2023

Status Verified

June 1, 2023

Enrollment Period

11 months

First QC Date

May 8, 2023

Last Update Submit

June 9, 2023

Conditions

Nephrocalcinosis

Outcome Measures

Primary Outcomes (1)

  • percentage of nephrocalcinosis among renal diseases

    percentage of children presented with nephrocalcinosis among all children with renal diseses in sohag university hospital

    one year

Secondary Outcomes (1)

  • Percentage of each risk factor of Nephrocalcinosis

    one year

Eligibility Criteria

Age1 Month - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

all infants and children diagnosed with nephrocalcinosis and followed up at our pediatric nephrology clinic and pediatric department at Sohag University Hospitals during the study duration

You may qualify if:

  • All patients aged from one month to 12 years diagnosed with nephrocalcinosis at pediatric department and nephrology outpatient clinic.

You may not qualify if:

  • Children with nephrolithiasis without nephrocalcinosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Monet-Didailler C, Chateil JF, Allard L, Godron-Dubrasquet A, Harambat J. [Nephrocalcinosis in children]. Nephrol Ther. 2021 Feb;17(1):58-66. doi: 10.1016/j.nephro.2020.12.001. Epub 2021 Jan 15. French.

    PMID: 33461896RESULT

  • Hoppe B, Martin-Higueras C, Younsi N, Stein R. [Nephrolithiasis and nephrocalcinosis in children and adolescents]. Urologie. 2022 Oct;61(10):1099-1109. doi: 10.1007/s00120-022-01888-3. Epub 2022 Jul 8. German.

    PMID: 35925106RESULT

  • Habbig S, Beck BB, Hoppe B. Nephrocalcinosis and urolithiasis in children. Kidney Int. 2011 Dec;80(12):1278-91. doi: 10.1038/ki.2011.336. Epub 2011 Sep 28.

    PMID: 21956187RESULT

MeSH Terms

Conditions

Nephrocalcinosis

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesCalcinosisCalcium Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Central Study Contacts

Menna Saad Mohamed, master degree

CONTACT

0158112682menasaad@med.sohag.edu.eg

Ghada Ashry Borham, lecturer

CONTACT

01068479255

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident doctor

Study Record Dates

First Submitted

May 8, 2023

First Posted

May 17, 2023

Study Start

June 1, 2023

Primary Completion

May 1, 2024

Study Completion

May 1, 2024

Last Updated

June 13, 2023

Record last verified: 2023-06